20-64048520-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_018419.3(SOX18):c.801G>A(p.Ala267Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00603 in 1,220,490 control chromosomes in the GnomAD database, including 272 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.026 ( 164 hom., cov: 33)
Exomes 𝑓: 0.0031 ( 108 hom. )
Consequence
SOX18
NM_018419.3 synonymous
NM_018419.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.415
Publications
0 publications found
Genes affected
SOX18 (HGNC:11194): (SRY-box transcription factor 18) This gene encodes a member of the SOX (SRY-related HMG-box) family of transcription factors involved in the regulation of embryonic development and in the determination of the cell fate. The encoded protein may act as a transcriptional regulator after forming a protein complex with other proteins. This protein plays a role in hair, blood vessel, and lymphatic vessel development. Mutations in this gene have been associated with recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia. [provided by RefSeq, Jul 2008]
SOX18 Gene-Disease associations (from GenCC):
- hypotrichosis-lymphedema-telangiectasia-renal defect syndromeInheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
- hypotrichosis-lymphedema-telangiectasia syndromeInheritance: AR, AD Classification: STRONG, MODERATE, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
- hypotrichosis-lymphedema-telangiectasia syndrome (grouping)Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.4).
BP6
Variant 20-64048520-C-T is Benign according to our data. Variant chr20-64048520-C-T is described in ClinVar as Benign. ClinVar VariationId is 261031.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.415 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0849 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SOX18 | NM_018419.3 | c.801G>A | p.Ala267Ala | synonymous_variant | Exon 2 of 2 | ENST00000340356.9 | NP_060889.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SOX18 | ENST00000340356.9 | c.801G>A | p.Ala267Ala | synonymous_variant | Exon 2 of 2 | 1 | NM_018419.3 | ENSP00000341815.7 |
Frequencies
GnomAD3 genomes AF: 0.0265 AC: 3992AN: 150868Hom.: 163 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
3992
AN:
150868
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00 AC: 0AN: 472 AF XY: 0.00
GnomAD2 exomes
AF:
AC:
0
AN:
472
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00314 AC: 3363AN: 1069514Hom.: 108 Cov.: 31 AF XY: 0.00303 AC XY: 1529AN XY: 505392 show subpopulations
GnomAD4 exome
AF:
AC:
3363
AN:
1069514
Hom.:
Cov.:
31
AF XY:
AC XY:
1529
AN XY:
505392
show subpopulations
African (AFR)
AF:
AC:
1975
AN:
21764
American (AMR)
AF:
AC:
79
AN:
7528
Ashkenazi Jewish (ASJ)
AF:
AC:
101
AN:
12894
East Asian (EAS)
AF:
AC:
0
AN:
24064
South Asian (SAS)
AF:
AC:
3
AN:
21514
European-Finnish (FIN)
AF:
AC:
1
AN:
21380
Middle Eastern (MID)
AF:
AC:
27
AN:
2792
European-Non Finnish (NFE)
AF:
AC:
854
AN:
915222
Other (OTH)
AF:
AC:
323
AN:
42356
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
183
366
548
731
914
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
100
200
300
400
500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0264 AC: 3993AN: 150976Hom.: 164 Cov.: 33 AF XY: 0.0249 AC XY: 1835AN XY: 73760 show subpopulations
GnomAD4 genome
AF:
AC:
3993
AN:
150976
Hom.:
Cov.:
33
AF XY:
AC XY:
1835
AN XY:
73760
show subpopulations
African (AFR)
AF:
AC:
3608
AN:
41344
American (AMR)
AF:
AC:
228
AN:
15168
Ashkenazi Jewish (ASJ)
AF:
AC:
35
AN:
3450
East Asian (EAS)
AF:
AC:
0
AN:
5160
South Asian (SAS)
AF:
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
AC:
0
AN:
10152
Middle Eastern (MID)
AF:
AC:
8
AN:
290
European-Non Finnish (NFE)
AF:
AC:
65
AN:
67586
Other (OTH)
AF:
AC:
49
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
181
361
542
722
903
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Oct 11, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 06, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.